Policy Cures Research’s G-FINDER 2020 Report Tracks Global Funding On Emerging Infectious Diseases R&D

Policy Cures Research: Amidst COVID-19, Disease X looms and more cross-cutting R&D funds needed for all emerging infectious diseases, says new G-FINDER report
“Emerging infectious diseases — both known and unknown — remain a constant threat as the world fights COVID-19, yet past R&D investments show the need for more consistent and diversified funding to prevent future pandemics, according to the new G-FINDER report on emerging infectious disease (EID) by Policy Cures Research, a global health think tank. The report, Landscape of Emerging Infectious Disease R&D: Preventing the next pandemic, tracks global funding for basic research and products such as vaccines, therapeutics, and diagnostics to fight priority EIDs, including coronaviruses, Ebola, and Zika, as well as Disease X — the name given to unknown pathogens with pandemic potential — between 2014 and 2018…” (9/17).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.